Kindai University Hospital
Osaka Sayama, Japan
University hospital in Osakasayama
377-2 Onohigashi, Osakasayama, Osaka 589-8511
About Kindai University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
10
Daiichi Sankyo, Inc.
8
Celgene
7
Loxo Oncology, Inc.
5
Haruhiko Fukuda
4
Pfizer
4
Eli Lilly and Company
3
Janssen Pharmaceutical K.K.
3
Chugai Pharmaceutical
2
Incyte Corporation
2
Japan Clinical Oncology Group
2
Clinical Trials at Kindai University Hospital
During the past decade, Kindai University Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 10 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 8 clinical trials were completed. i.e. 29.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
2002-06-01
2014-03-01
Completed
500
Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
1999-08-01
2006-11-01
Completed
80
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
2002-09-01
2011-09-01
Completed
281
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
2005-11-01
2015-04-01
Completed
316
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
2006-02-01
2011-11-01
Completed
253
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma
2008-04-24
2009-12-22
Terminated
54
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
2010-12-06
2016-12-20
Completed
224
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 10 trials, followed by "Daiichi Sankyo, Inc." with 8 trials
sponsored, "Celgene" with 7 trials sponsored, "Loxo Oncology, Inc." with 5 trials sponsored and "Haruhiko Fukuda"
with 5 trials sponsored. Other sponsors include 23 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital"
#1 collaborator was "AstraZeneca" with 6 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at Kindai University Hospital
According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are
"Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Myelodysplastic Syndromes" (3 trials), "Non-small Cell Lung Cancer" (3 trials) and "Advanced Hepatocellular Carcinoma" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kindai University Hospital
Most popular intervention types in "Kindai University Hospital" are "Drug" (57 trials), "Other" (5 trials), "Procedure" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Apalutamide" (3 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Kindai University Hospital
The vast majority of trials in "Kindai University Hospital" are
53 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Kindai University Hospital
Currently, there are NaN active trials in "Kindai University Hospital".
undefined are not yet recruiting,
26 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Kindai University Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kindai University Hospital, 5 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".